USP11 and cancer: The dysregulation of USP11 is associated with multiple diseases and pathological processes, and cancer therapies targeting USP11 have achieved expected clinical value and are gradually becoming an emerging therapeutic target for a variety of cancers, receiving attention from numerous researchers and scholars.